Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy

Abstract excerpt

Phase I clinical trials generally raise greater ethical and human protection challenges than later stage clinical trials, suggesting a need to proceed cautiously. This is particularly the case for Phase I trials with a novel therapy being tested in humans for the first time, usually termed first-in-human (FIH) trials. In January 2009, the Food and Drug Administration approved the Investigational New Drug...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to 3D Printing in Biomedical Research
• Share to Biomedical Ethics and Regulation
• Share to Pluripotent Stem Cells Research